Systemic application of carbon monoxide-releasing molecule 3 protects skeletal muscle from ischemia-reperfusion injury

Journal of Vascular Surgery

Volumn 66, Issue 6, 2017, Pages 1864-1871

  Bihari, Aurelia ^a,b   Cepinskas, Gediminas ^a,b   Forbes, Thomas L ^c   Potter, Richard F ^a,b   Lawendy, Abdel Rahman ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE RELEASING MOLECULE 3; CARBONYL DERIVATIVE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; AUTACOID; CARBON MONOXIDE; ORGANOMETALLIC COMPOUND; TRICARBONYLCHLORO(GLYCINATO)RUTHENIUM(II);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CAPILLARY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EXTENSOR DIGITORUM LONGUS MUSCLE; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LIMB ISCHEMIA; MALE; MUSCLE PERFUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; SYSTEMIC THERAPY; TISSUE INJURY; VIDEO MICROSCOPY; ANIMAL; BLOOD; BLOOD FLOW; BLOOD FLOW VELOCITY; CELL ADHESION; DISEASE MODEL; DRUG EFFECTS; HINDLIMB; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKOCYTE; METABOLISM; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; TIME FACTOR; VASCULARIZATION; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD FLOW VELOCITY; CARBON MONOXIDE; CELL ADHESION; DISEASE MODELS, ANIMAL; HINDLIMB; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; LEUKOCYTES; MALE; MICROCIRCULATION; MUSCLE, SKELETAL; ORGANOMETALLIC COMPOUNDS; RATS, WISTAR; REGIONAL BLOOD FLOW; REPERFUSION INJURY; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85012872373     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2016.11.065     Document Type: Article

References (40)

1. Bywaters, E.G., Ischemic muscle necrosis: crushing injury, traumatic edema, the crush syndrome, traumatic anuria, compression syndrome: a type of injury seen in air raid casualties following burial beneath debris. JAMA 124 (1944), 1103–1109.
2. Dennis, C., Disaster following femoral vein ligation for thrombophlebitis. Surgery 17 (1945), 265–270.
3. Blaisdell, F.W., The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg 10 (2002), 620–630.
4. Forbes, T.L., Carson, M., Harris, K.A., DeRose, G., Jamieson, W.G., Potter, R.F., Skeletal muscle injury induced by ischemia-reperfusion. Can J Surg 38 (1995), 56–63.
5. Forbes, T.L., Harris, K.A., Jamieson, W.G., DeRose, G., Carson, M., Potter, R.F., Leukocyte activity and tissue injury following ischemia-reperfusion in skeletal muscle. Microvasc Res 51 (1996), 275–287.
6. Lawendy, A.R., Sanders, D.W., Bihari, A., Parry, N., Gray, D., Badhwar, A., Compartment syndrome-induced microvascular dysfunction: an experimental rodent model. Can J Surg 54 (2011), 194–200.
7. Sadasivan, K.K., Carden, D.L., Moore, M.B., Korthuis, R.J., Neutrophil mediated microvascular injury in acute, experimental compartment syndrome. Clin Orthop Relat Res, 1997, 206–215.
8. Gillani, S., Cao, J., Suzuki, T., Hak, D.J., The effect of ischemia reperfusion injury on skeletal muscle. Injury 43 (2012), 670–675.
9. Nakao, A., Kimizuka, K., Stolz, D.B., Neto, J.S., Kaizu, T., Choi, A.M., et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol 163 (2003), 1587–1598.
10. Ott, M.C., Scott, J.R., Bihari, A., Badhwar, A., Otterbein, L.E., Gray, D.K., et al. Inhalation of carbon monoxide prevents liver injury and inflammation following hind limb ischemia/reperfusion. FASEB J 19 (2005), 106–108.
11. Motterlini, R., Mann, B.E., Foresti, R., Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 14 (2005), 1305–1318.
12. Motterlini, R., Otterbein, L.E., The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9 (2010), 728–743.
13. Motterlini, R., Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. Biochem Soc Trans 35 (2007), 1142–1146.
14. Cepinskas, G., Katada, K., Bihari, A., Potter, R.F., Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 294 (2008), G184–G191.
15. Mizuguchi, S., Stephen, J., Bihari, A., Markovic, N., Suehiro, S., Capretta, A., et al. CORM-3-derived CO modulates polymorphonuclear leukocyte migration across the vascular endothelium by reducing levels of cell surface-bound elastase. Am J Physiol Heart Circ Physiol 297 (2009), H920–H929.
16. Lawendy, A.R., Bihari, A., Sanders, D.W., Potter, R.F., Cepinskas, G., The severity of microvascular dysfunction due to compartment syndrome is diminished by the systemic application of CO-releasing molecule-3. J Orthop Trauma 28 (2014), e263–e268.
17. Clark, J.E., Naughton, P., Shurey, S., Green, C.J., Johnson, T.R., Mann, B.E., et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93 (2003), e2–e8.
18. Baxter-Smith, D., Ashton, F., Slaney, G., Peripheral arterial embolism. A 20 year review. J Cardiovasc Surg (Torino) 29 (1988), 453–457.
19. Varty, K., St Johnston, J.A., Beets, G., Campbell, W.B., Arterial embolectomy. A long-term perspective. J Cardiovasc Surg (Torino) 33 (1992), 79–84.
20. Linfert, D., Chowdhry, T., Rabb, H., Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 23 (2009), 1–10.
21. Eliason, J.L., Wainess, R.M., Proctor, M.C., Dimick, J.B., Cowan, J.A. Jr., Upchurch, G.R. Jr., et al. A national and single institutional experience in the contemporary treatment of acute lower extremity ischemia. Ann Surg 238 (2003), 382–389 discussion: 389-90.
22. Mayr, F.B., Spiel, A., Leitner, J., Marsik, C., Germann, P., Ullrich, R., et al. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am J Respir Crit Care Med 171 (2005), 354–360.
23. Fujita, T., Toda, K., Karimova, A., Yan, S.F., Naka, Y., Yet, S.F., et al. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7 (2001), 598–604.
24. Katada, K., Bihari, A., Mizuguchi, S., Yoshida, N., Yoshikawa, T., Fraser, D.D., et al. Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine. Inflammation 33 (2010), 92–100.
25. Guo, Y., Stein, A.B., Wu, W.J., Tan, W., Zhu, X., Li, Q.H., et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286 (2004), H1649–H1653.
26. Caumartin, Y., Stephen, J., Deng, J.P., Lian, D., Lan, Z., Liu, W., et al. Carbon monoxide-releasing molecules protect against ischemia-reperfusion injury during kidney transplantation. Kidney Int 79 (2011), 1080–1089.
27. Wei, Y., Chen, P., de Bruyn, M., Zhang, W., Bremer, E., Helfrich, W., Carbon monoxide-releasing molecule-2 (CORM-2) attenuates acute hepatic ischemia reperfusion injury in rats. BMC Gastroenterol, 10, 2010, 42.
28. Nanobashvili, J., Neumayer, C., Fuegl, A., Blumer, R., Prager, M., Sporn, E., et al. Development of 'no-reflow' phenomenon in ischemia/reperfusion injury: failure of active vasomotility and not simply passive vasoconstriction. Eur Surg Res 35 (2003), 417–424.
29. Tuma, R.F., Durian, W.N., Ley, K., Handbook of physiology: microcirculation. 2nd ed., 2008, Academic Press (Elsevier), Oxford, UK.
30. Gute, D.C., Ishida, T., Yarimizu, K., Korthuis, R.J., Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179 (1998), 169–187.
31. Lindsay, T.F., Liauw, S., Romaschin, A.D., Walker, P.M., The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle. J Vasc Surg 12 (1990), 8–15.
32. Mizuguchi, S., Capretta, A., Suehiro, S., Nishiyama, N., Luke, P., Potter, R.F., et al. Carbon monoxide-releasing molecule CORM-3 suppresses vascular endothelial cell SOD-1/SOD-2 activity while up-regulating the cell surface levels of SOD-3 in a heparin-dependent manner. Free Radic Biol Med 49 (2010), 1534–1541.
33. Lancel, S., Montaigne, D., Marechal, X., Marciniak, C., Hassoun, S.M., Decoster, B., et al. Carbon monoxide improves cardiac function and mitochondrial population quality in a mouse model of metabolic syndrome. PLoS One, 7, 2012, e41836.
34. Patterson, E.K., Fraser, D.D., Capretta, A., Potter, R.F., Cepinskas, G., Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction. Free Radic Biol Med 70 (2014), 167–173.
35. Galasso, G., Schiekofer, S., D'Anna, C., Gioia, G.D., Piccolo, R., Niglio, T., et al. No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives. Angiology 65 (2014), 180–189.
36. Toyokuni, S., Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 49 (1999), 91–102.
37. Brock, R.W., Lawlor, D.K., Harris, K.A., Potter, R.F., Initiation of remote hepatic injury in the rat: interactions between Kupffer cells, tumor necrosis factor-alpha, and microvascular perfusion. Hepatology 30 (1999), 137–142.
38. Motterlini, R., Haas, B., Foresti, R., Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs). Med Gas Res, 2, 2012, 28.
39. Vadori, M., Seveso, M., Besenzon, F., Bosio, E., Tognato, E., Fante, F., et al. In vitro and in vivo effects of the carbon monoxide-releasing molecule, CORM-3, in the xenogeneic pig-to-primate context. Xenotransplantation 16 (2009), 99–114.
40. Song, H., Bergstrasser, C., Rafat, N., Hoger, S., Schmidt, M., Endres, N., et al. The carbon monoxide releasing molecule (CORM-3) inhibits expression of vascular cell adhesion molecule-1 and E-selectin independently of haem oxygenase-1 expression. Br J Pharmacol 157 (2009), 769–780.